Panacea Biotec Limited (NSE:PANACEABIO)
India flag India · Delayed Price · Currency is INR
351.30
+17.40 (5.21%)
Mar 10, 2026, 10:40 AM IST

Panacea Biotec Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Revenue
6,0565,5915,5924,5996,6126,248
Upgrade
Revenue Growth (YoY)
7.56%-0.01%21.57%-30.44%5.83%14.84%
Upgrade
Cost of Revenue
2,5621,9952,3012,5272,6222,046
Upgrade
Gross Profit
3,4943,5963,2902,0733,9904,202
Upgrade
Selling, General & Admin
2,0731,9731,6431,5172,0501,774
Upgrade
Other Operating Expenses
1,6841,8041,6951,1921,9871,544
Upgrade
Operating Expenses
4,0944,1253,7053,1004,4743,774
Upgrade
Operating Income
-599.68-529.78-414.69-1,027-484.18427.33
Upgrade
Interest Expense
-49.32-29.22-26.73-38.03-1,798-1,847
Upgrade
Interest & Investment Income
77.1277.1284.07120.6233.9432.68
Upgrade
Earnings From Equity Investments
-----0.77
Upgrade
Currency Exchange Gain (Loss)
36.9936.9936.2320.775.8-6.88
Upgrade
Other Non Operating Income (Expenses)
13.26-9.54-9.08-6.34-10.02-6.45
Upgrade
EBT Excluding Unusual Items
-521.63-454.43-330.2-930.37-2,253-1,399
Upgrade
Gain (Loss) on Sale of Investments
24.524.533.4114.470.01-
Upgrade
Gain (Loss) on Sale of Assets
4.464.46-2.6452.930.07-0.38
Upgrade
Asset Writedown
-13.95-13.95-46.14-29.94-15.75-42.63
Upgrade
Other Unusual Items
445.04359.94360.341,02116,762-
Upgrade
Pretax Income
-61.58-79.4814.77128.0514,494-1,442
Upgrade
Income Tax Expense
19.917.7129.82465.53,71019.57
Upgrade
Earnings From Continuing Operations
-81.49-87.19-15.05-337.4510,783-1,462
Upgrade
Earnings From Discontinued Operations
------14.55
Upgrade
Net Income to Company
-81.49-87.19-15.05-337.4510,783-1,477
Upgrade
Minority Interest in Earnings
3.693.493.325.08-0.19-0.38
Upgrade
Net Income
-77.8-83.7-11.73-332.3710,783-1,477
Upgrade
Net Income to Common
-77.8-83.7-11.73-332.3710,783-1,477
Upgrade
Shares Outstanding (Basic)
616161616161
Upgrade
Shares Outstanding (Diluted)
616161616161
Upgrade
EPS (Basic)
-1.28-1.37-0.19-5.43176.05-24.11
Upgrade
EPS (Diluted)
-1.28-1.37-0.19-5.43176.05-24.11
Upgrade
Free Cash Flow
--776.74-794.08-4,634-1,210848.87
Upgrade
Free Cash Flow Per Share
--12.68-12.96-75.66-19.7513.86
Upgrade
Gross Margin
57.70%64.31%58.85%45.07%60.35%67.25%
Upgrade
Operating Margin
-9.90%-9.48%-7.42%-22.34%-7.32%6.84%
Upgrade
Profit Margin
-1.29%-1.50%-0.21%-7.23%163.08%-23.64%
Upgrade
Free Cash Flow Margin
--13.89%-14.20%-100.75%-18.29%13.59%
Upgrade
EBITDA
-292.34-207.64-72.82-641.24-56.28872.65
Upgrade
EBITDA Margin
-4.83%-3.71%-1.30%-13.94%-0.85%13.97%
Upgrade
D&A For EBITDA
307.34322.14341.87386.15427.9445.32
Upgrade
EBIT
-599.68-529.78-414.69-1,027-484.18427.33
Upgrade
EBIT Margin
-9.90%-9.48%-7.42%-22.34%-7.32%6.84%
Upgrade
Effective Tax Rate
--201.90%363.53%25.60%-
Upgrade
Revenue as Reported
6,2855,7985,8505,1166,7226,348
Upgrade
Advertising Expenses
-194.73113.04218.21220.05183.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.